thalidomide has been researched along with Conus Medullaris Syndrome in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, D | 1 |
| Stevens, J | 1 |
| Quinn, J | 1 |
| Cavenagh, J | 1 |
| Ingram, W | 1 |
| Yong, K | 1 |
| Smith, JR | 1 |
| Martin, IR | 1 |
| Shaw, DG | 1 |
| Robinson, RO | 1 |
2 other studies available for thalidomide and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Myeloma presenting during pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cesarean Section; | 2014 |
Progressive non-infectious anterior vertebral fusion.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Female; Fetal Diseases; Humans; Kyphosis; Lumbar V | 1986 |